Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInt.biotech. Regulatory News (IBT)

Share Price Information for Int.biotech. (IBT)

Share Price is delayed by 15 minutes
Get Live Data
990.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 10.00 (1.016%)
Market Cap: £315.10m
IBT Live PriceLast checked at - London Stock Exchange

Intraday Int.biotech. Share Chart

Dividend Declaration

1 Jul 2025 07:00

RNS Number : 0665P
Intl. Biotechnology Trust PLC
01 July 2025
 

1 July 2025

 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC

 

Second interim dividend for the year ending 31 August 2025

 

At the Annual General Meeting of International Biotechnology Trust plc (the "Company") held on 9 December 2024, shareholders approved the Company's dividend policy of making dividend payments, equivalent to 4% of the Company's net asset value as at the last day of the preceding financial year (31 August 2024), through two equal semi-annual distributions.

 

The Directors have declared the payment of a second interim dividend of 16.17 pence per ordinary share for the year ending 31 August 2025.

 

In addition, the Company paid the first interim dividend of 15.56 pence per ordinary share for the year ending 31 August 2025 on 24 January 2025.

 

As at 27 June 2025, the latest practicable date prior to publication of this announcement, an annual dividend of 31.73 pence per share represents a yield of 5.40% calculated with reference to the Company's closing share price of 588 pence on 27 June 2025.

  

Ex-dividend date:

24 July 2025

Record date:

25 July 2025

Payment date:

22 August 2025

Dividend per share:

16.17 pence

 

 

Enquiries:

Kerry Higgins

Schroder Investment Management Limited

Tel: 020 7658 6000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVFMMFTMTTJBPA
Date   Source Headline
14th Apr 202611:41 amRNSNet Asset Value(s)
13th Apr 202611:51 amRNSNet Asset Value(s)
10th Apr 20264:40 pmRNSCompliance with Market Abuse Regulation
10th Apr 202612:06 pmRNSNet Asset Value(s)
9th Apr 202611:32 amRNSNet Asset Value(s)
8th Apr 202611:50 amRNSNet Asset Value(s)
7th Apr 20265:15 pmRNSTransaction in Own Shares
7th Apr 202611:56 amRNSNet Asset Value(s)
7th Apr 202610:25 amRNS-RPortfolio company Soleno acquired by Neurocrine
1st Apr 20265:24 pmRNSTransaction in Own Shares
1st Apr 202612:02 pmRNSNet Asset Value(s)
31st Mar 20262:55 pmRNS-RIBT portfolio company Apellis acquired by Biogen
31st Mar 202612:00 pmRNSNet Asset Value(s)
30th Mar 202611:46 amRNSNet Asset Value(s)
27th Mar 202611:51 amRNSNet Asset Value(s)
26th Mar 202611:56 amRNSNet Asset Value(s)
25th Mar 20262:43 pmRNS-RIBT portfolio company Terns acquired by Merck
25th Mar 202612:01 pmRNSNet Asset Value(s)
24th Mar 202611:54 amRNSNet Asset Value(s)
23rd Mar 202611:56 amRNSNet Asset Value(s)
20th Mar 202611:54 amRNSNet Asset Value(s)
19th Mar 202611:54 amRNSNet Asset Value(s)
18th Mar 202611:45 amRNSNet Asset Value(s)
17th Mar 202611:28 amRNSNet Asset Value(s)
16th Mar 202611:52 amRNSNet Asset Value(s)
13th Mar 202611:52 amRNSNet Asset Value(s)
12th Mar 20267:00 amRNS-RKepler Trust Intelligence: New Research
11th Mar 202611:56 amRNSNet Asset Value(s)
9th Mar 202611:48 amRNSNet Asset Value(s)
9th Mar 20268:42 amRNS-RPortfolio company Day One acquired by Servier
6th Mar 202611:42 amRNSNet Asset Value(s)
5th Mar 202612:02 pmRNSNet Asset Value(s)
4th Mar 202611:49 amRNSNet Asset Value(s)
3rd Mar 202611:35 amRNSNet Asset Value(s)
2nd Mar 202612:24 pmRNSNet Asset Value(s)
27th Feb 202611:14 amRNSNet Asset Value(s)
26th Feb 202611:49 amRNSNet Asset Value(s)
25th Feb 202611:54 amRNSNet Asset Value(s)
24th Feb 202611:43 amRNSNet Asset Value(s)
23rd Feb 202611:40 amRNSNet Asset Value(s)
20th Feb 202610:53 amRNSNet Asset Value(s)
19th Feb 202611:36 amRNSNet Asset Value(s)
18th Feb 202611:47 amRNSNet Asset Value(s)
17th Feb 202611:32 amRNSNet Asset Value(s)
16th Feb 202611:56 amRNSNet Asset Value(s)
13th Feb 202611:52 amRNSNet Asset Value(s)
12th Feb 202611:04 amRNSNet Asset Value(s)
11th Feb 202611:24 amRNSNet Asset Value(s)
10th Feb 202612:02 pmRNSRestatement of Net Asset Value(s)
10th Feb 202611:41 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.